Provider Recommendations in the Face of Scientific Uncertainty: An Analysis of Audio-Recorded Discussions about Vitamin D

Journal of General Internal Medicine

Volumn 31, Issue 8, 2016, Pages 909-917

  Tarn, Derjung M ^a   Paterniti, Debora A ^b,c   Wenger, Neil S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SONOMA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

complementary and alternative medicine; dietary supplements; provider patient relations; qualitative research methods; scientific uncertainty; vitamin D

Indexed keywords

VITAMIN D;

ADULT; ALTERNATIVE MEDICINE; AMBULATORY CARE; ARTICLE; AUDIO RECORDING; CONTENT ANALYSIS; CONVENIENCE SAMPLE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTEGRATIVE MEDICINE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCIENTIFIC LITERATURE; SCREENING; UNCERTAINTY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; AGED; ATTITUDE TO HEALTH; BLOOD; CROSS-SECTIONAL STUDY; DIET THERAPY; DIETARY SUPPLEMENT; DOCTOR PATIENT RELATION; GENERAL PRACTITIONER; MIDDLE AGED; PATIENT EDUCATION; PROCEDURES; RECORDING; STANDARDS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, PRIMARY CARE; TAPE RECORDING; UNCERTAINTY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84961771232     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-016-3667-5     Document Type: Article

References (34)

1. Fox RC. The evolution of medical uncertainty. The Milbank Memorial Fund quarterly Health and Society. 1980;58(1):1–49.
2. Gordon GH, Joos SK, Byrne J. Physician expressions of uncertainty during patient encounters. Patient Educ Couns. 2000;40(1):59–65.
3. Henry MS. Uncertainty, responsibility, and the evolution of the physician/patient relationship. Journal of Medical Ethics. 2006;32(6):321–323.
4. Hewson MG, Kindy PJ, Van Kirk J, Gennis VA, Day RP. Strategies for managing uncertainty and complexity. J Gen Intern Med. 1996;11(8):481–485.
5. Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282(24):2313–2320.
6. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994). NCHS Data Brief. 2011(61):1–8.
7. Rollins G. Vitamin D, testing—what’s the right answer? Clinical Laboratory News. 2009;35(1):6–8.
8. LeFevre ML, Force USPST. Screening for vitamin d deficiency in adults: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2015;162(2):133–140.
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97(4):1153–1158.
10. Institute of Medicine (U.S.). Dietary Reference Intakes for Calcium and Vitamin D. Washington: The National Academies Press; 2011.
11. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012;97(4):1146–1152.
12. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
13. Moyer VA, Force* USPST. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;158(9):691–696.
14. LeBlanc ES, Zakher B, Daeges M, Pappas M, Chou R. Screening for vitamin D deficiency: a systematic review for the U.S. Preventive Services Task Force. Annals Internal Med. 2014.
15. LeBlanc ECR, Zakhler B, Fraenkel M, Pappas M. Screening for Vitamin D Deficiency: Systematic Review for the U.S. Preventive Services Task Force Recommendation. Evidence Synthesis No. 118. AHRQ Publication No. 13-05183-EF-1. Rockville: Agency for Healthcare Research and Quality; 2014.
16. Tarn DM, Karlamangla A, Coulter ID, et al. A cross-sectional study of provider and patient characteristics associated with outpatient disclosures of dietary supplement use. Patient Educ Couns. 2015;98(7):830–836.
17. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–282.
18. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149(4):242–250.
19. Cauley JA, Parimi N, Ensrud KE, et al. Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res. 2010;25(3):545–553.
20. Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M. Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporis Int. 2008;19(7):991–999.
21. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporis Int. 2005;16(11):1425–1431.
22. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999;281(16):1505–1511.
23. Looker AC. Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults. J Bone Miner Res. 2013;28(5):997–1006.
24. Melhus H, Snellman G, Gedeborg R, et al. Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab. 2010;95(6):2637–2645.
25. Verhoef MJ, Mulkins A, Carlson LE, Hilsden RJ, Kania A. Assessing the role of evidence in patients’ evaluation of complementary therapies: a quality study. Integr Cancer Ther. 2007;6(4):345–353.
26. Enkin MW, Jadad AR. Using anecdotal information in evidence-based health care: heresy or necessity? Ann Oncol. 1998;9(9):963–966.
27. Caruso D, English RA, Claiborne AB, Institute of Medicine (U.S.). Forum on Drug Discovery Development and Translation. Characterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products: workshop summary. Washington: The National Academies Press; 2014.
28. Politi MC, Street RL Jr. The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty. J Eval Clin Pract. 2011;17(4):579–584.
29. Blanch DC, Hall JA, Roter DL, Frankel RM. Is it good to express uncertainty to a patient? Correlates and consequences for medical students in a standardized patient visit. Patient Educ Couns. 2009;76(3):300–306.
30. Johnson CG, Levenkron JC, Suchman AL, Manchester R. Does physician uncertainty affect patient satisfaction? J Gen Intern Med. 1988;3(2):144–149.
31. Ogden J, Fuks K, Gardner M, et al. Doctors expressions of uncertainty and patient confidence. Patient Educ Couns. 2002;48(2):171–176.
32. Alshahrani F, Aljohani N. Vitamin D: deficiency, sufficiency and toxicity. Nutrients. 2013;5(9):3605–3616.
33. Bischoff-Ferrari HA, Dawson-Hughes B, Orave EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline [published online January 4, 2016]. JAMA Intern Med. 2016. doi:10.1001/jamainternmed.2015.7148.
34. Themessl-Huber M, Humphris G, Dowell J, Macgillivray S, Rushmer R, Williams B. Audio-visual recording of patient-GP consultations for research purposes: a literature review on recruiting rates and strategies. Patient Educ Couns. 2008;71(2):157–168.